Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects

NCT04451083 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: FOY-305

Sponsor

Ono Pharmaceutical Co., Ltd.